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aBstraCt
Background and Aims: additive manufacturing or three-dimensional printing is a novel 
production methodology for producing patient-specific models, medical aids, tools, and 
implants. however, the clinical impact of this technology is unknown. in this study, we 
sought to characterize the clinical adoption of medical additive manufacturing in finland 
in 2016–2017. We focused on non-dental usage at university hospitals.
Materials and Methods: a questionnaire containing five questions was sent by email 
to all operative, radiologic, and oncologic departments of all university hospitals in 
finland. respondents who reported extensive use of medical additive manufacturing 
were contacted with additional, personalized questions.
Results: Of the 115 questionnaires sent, 58 received answers. Of the responders, 41% 
identified as non-users, including all general/gastrointestinal (gi) and vascular surgeons, 
urologists, and gynecologists; 23% identified as experimenters or previous users; and 
36% identified as heavy users. Usage was concentrated around the head area by various 
specialties (neurosurgical, craniomaxillofacial, ear, nose and throat diseases (ent), plastic 
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surgery). applications included repair of cranial vault defects and malformations, surgical 
oncology, trauma, and cleft palate reconstruction. some routine usage was also reported in 
orthopedics. in addition to these patient-specific uses, we identified several off-the-shelf 
medical components that were produced by additive manufacturing, while some important 
patient-specific components were produced by traditional methodologies such as milling.
Conclusion: during 2016–2017, medical additive manufacturing in finland was routinely 
used at university hospitals for several applications in the head area. Outside of this area, 
usage was much less common. future research should include all patient-specific products 
created by a computer-aided design/manufacture workflow from imaging data, instead of 
concentrating on the production methodology.
Key words: Computer-aided design; medical model; computer-assisted surgery; three-dimensional printing; 
3d printing
INTRODUCTION
Additive manufacturing (AM) or three-dimensional 
printing (3DP) is a production methodology where, 
instead of subtractive manufacturing like milling or 
drilling, or formative manufacturing like forging or 
bending, 3D products are built by the addition of mate-
rial, usually in successive layers (1). While specific AM 
technology names may differ between producers of 3D 
printers, the recent International Organization for 
Standardization (ISO)/ASTM International standard 
indicates seven groups of technologies: vat photopoly-
merization, material jetting, binder jetting, material 
extrusion, powder bed fusion, sheet lamination, and 
direct energy deposition (1). For a review on 3DP tech-
nologies, medical applications, and the required image 
processing, see Mitsouras et al. (2).
During the past decades, AM has found an increas-
ing number of applications in medicine. For the first 
time, AM has allowed the reproduction of complex 
patient geometry in models for surgical planning and 
education. AM has also been used for producing 
patient-specific implants (PSIs), tools such as saw 
guides, and to some degree custom-made supports and 
splints. While bioprinting (i.e. the printing of biological 
tissues or organs) has potentially revolutionary clinical 
implications, at present it is not in clinical use (3).
The literature on AM still mainly consists of case 
reports and small case series. Published applications 
illustrating the scope of possibilities include orbital 
reconstruction with a PSI (4), an endovascular aortic 
aneurysm repair facilitated by a 3D printed hollow 
model (5), a printed gynecological training simulator 
(6), and creating a printed death mask to cover the 
face of a facial allotransplant donor (7). However, 
reports of single, specific cases typically only offer 
proof of concept and provide weak evidence for their 
general practicality and efficiency. In order to impact 
daily practice, AM applications must be clinically 
and economically justifiable, providing better out-
comes or less costly operations, for example through 
reducing time spent in the operating room. To date, 
there has not been any randomized trials comparing 
AM methodologies with traditional approaches; the 
existing studies usually only report subjective surgeon 
satisfaction with the technology (8). Recently, several 
reviews have been published that concern AM in a 
specific medical specialty, such as otorhinolaryngology—
head and neck surgery (8), spine surgery (9), urology 
(10), and plastic surgery (11). However, the true scale 
of utilization and the impact of AM technology on 
clinical practice to date have not been studied.
In this study, we attempt to characterize the clinical 
adoption and use of medical AM technologies and 
their impact on medical practice in Finland during 
2016–2017. Our aim was to identify the fields—if 
any—where medical AM has reached routine status, 
and best practices have been established, which could 
potentially be transferred to other applications. 
Furthermore, we sought to identify the fields where 
AM application has been met with problems, which 
could provide opportunities for further research and 
problem solving. We chose to focus on non-dental 
applications of AM, though dental use is addressed in 
the “Discussion” section (Fig. 1).
MATERIALS AND METHODS
A structured questionnaire consisting of five ques-
tions (Table 1) was sent by email to all operative (i.e. 
surgery and associated subspecialties, orthopedics, 
ear, nose and throat diseases (ENT), gynecology etc.), 
oncologic, and radiologic departments at each of the 
five university hospitals in Finland. The questionnaire 
was addressed to the head of department or professor, 
as determined by the hospital’s web pages or by con-
tacting the department secretary. In addition, a num-
ber of individual clinicians at university hospitals who 
had previously expressed interest in using AM were 
contacted with the same questions. One of the ques-
tions asked was whether the respondent knew of any-
body else using AM at their hospital, and these persons 
were in turn sent the same questionnaire until a satu-
ration point was reached and no further users were 
identified.
If the person contacted did not reply to the email, a 
reminder was sent, after which contact by telephone 
was attempted. Respondents who had used AM more 
than once were sent additional individualized, open-
ended questions; these results are addressed in the 
“Discussion” section.
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RESULTS
The questionnaire was sent to 115 people, of whom 
68 (59%) eventually answered, either by email or tel-
ephone. Excluding those who only referred to another 
person, we recorded 58 responses (50% of the people 
to whom the questionnaire was sent), some of which 
were from different people in the same departments. 
Based on their reported usage, we broke down the 
responses into three categories: non-users, previous 
users and experimenters, and heavy users (Table 2). 
The frequencies are presented in Fig. 2.
NON-USERS
This group, who had never used AM, included all 
respondents from general/gastrointestinal (GI) sur-
gery, urology, vascular surgery, and gynecology.
The majority had not used any patient-specific 
products and had no plans for doing so in the fore-
seeable future. One gynecological department used 
manually produced vaginal dilatators that could 
potentially be manufactured by AM in the future. In 
addition, one urological department indicated that 
AM-produced preoperative models could perhaps be 
useful as planning aids.
Three responders from radiation oncology depart-
ments used various patient-specific products, namely, 
positioning devices, radiation shields, and so on, 
which were either commercial (thermoplastic, water 
cured, or vacuum-based systems) or manufactured by 
on-site Computer Numerical Control (CNC) milling 
of foam. Using AM for these applications in the future 
was viewed as a possibility.
PREVIOUS USERS AND ExPERIMENTERS
Respondents in this group had some AM experience 
but were not active users. Combining answers refer-
ring to the same usage, nine distinct usages were iden-
tified. The represented specialties were bone tumor, 
pediatric and lower limb orthopedics, cardiothoracic 
surgery, and interventional cardiology.
Two orthopedic surgeons from different bone 
tumor units had previously used PSIs and patient-
specific instrumentation (saw guides) for scapular and 
pelvic tumors. However, they were disappointed with 
the results and switched to modular prosthetics—in 
one case combined with virtual planning and intraop-
erative navigation. The number of implants previ-
ously used was undetermined.
Fig. 1. Previously realized medical AM products from 
collaborations between Aalto University and University of 
Helsinki: (A) prosthetic mask to cover the face of a facial 
allotransplant donor (training model based on volunteer), (B) 
heart with congenital malformation and previous repair, and (C) 
model of orbital floor fracture and custom-made implant, both 
manufactured by AM.
TABLE 1
List of questions asked in the questionnaire.
Question 
number Question
1 Does your department use additive 
manufacturing (3D printing) for clinical or 
research purposes? If yes, in which way?
2 Do you use other methods of manufacturing 
patient-specific products (e.g. machining)?
3 Do you buy patient-specific products from an 
outside provider, such as a company? If yes, 
what products, and from where?
4 Are you aware of another person or department 
in your hospital who uses the above-mentioned 
methods?
5 Can you or another person at your department 
be contacted for further questions (email/
telephone)?
Clinical use of additive manufacturing in Finland 2016–2017 169
Two pediatric cardiothoracic surgeons had ordered 
a single model of a child’s heart with a congenital mal-
formation, and another cardiothoracic surgeon had 
modeled a sternum to test the possibilities of AM 
applications.
One interventional cardiologist had ordered two 
models of hearts with complex congenital deformities, 
which were used to plan and practice a catheter-based 
endovascular repair.
Six orthopedic surgeons from three different lower 
limb units reported previous experience with AM. 
One department had printed two preoperative mod-
els of a foot and a leg, another department printed one 
model of a leg, and the third department printed one 
model of a foot. In addition, one pediatric orthopedic 
surgeon reported having experimented with preoper-
ative models for bone deformities. All cases were 
especially complex deformities, either congenital or 
the result of malunited fractures.
Excluding the bone tumor users, all cases were 
experimental and ordered for especially complex and 
unique cases in order to determine if a printed preop-
erative model would be helpful. The models were seen 
as moderately useful but ultimately not worth the 
investment for further routine use.
HEAVy USERS
Heavy usage largely applied to the head region, 
with users specialized in maxillofacial surgery, ENT, 
plastic surgery, pediatric surgery, orthopedics, and 
neurosurgery (Table 3).
Six neurosurgeons from four different departments 
reported using patient-specific skull reconstruction 
implants for hemicraniectomy repair. These were 
ordered from various companies, which in turn use AM 
at least as a part of their manufacturing process. The 
cumulative volume of PSIs ordered was estimated to be 
around 50. The process of ordering PSIs had strongly 
modified common practice, in that neurosurgical depart-
ments had stopped freezing autologic bone grafts, since 
the results with synthetic implants were superior.
Four craniomaxillofacial (CMF) surgeons from 
three different departments, five ENT surgeons from 
four different departments, and two plastic surgeons 
from one department reported extensive use of AM 
for preoperative planning models, osteotomy saw 
guides, and implants. Cumulatively, the CMF sur-
geons used about 250 PSIs, 20 planning models, and 
20 saw guides per year. The use of printed planning 
models for CMF applications had diminished 
because of a transition toward virtual planning. The 
listed benefits of AM were shortened operative times 
and improved precision, especially in mandibular 
surgery, where surgeons credited PSIs with ability to 
TABLE 2
Answers by specialty.
Specialty Experimenter Previous user Heavy user No usage Referral No answer
Plastic 2 3
CMF 4 1 4
ENT 5 2 4
Neuro 6 2 1
Orthopedic 7 2 2 4 2 10
Thoracic 3 1 4
Pediatric 1 1
Cardiology 1  
Radiology 1 1 1 6
GI surgery 4 2 4
Urology 2 1
Vascular 1 1
Gynecology 6 1 5
Oncology 3 1 3
Total 11 2 21 24 10 47
AM: additive manufacturing.
Fig. 2. Breakdown of respondents by AM usage.
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produce truly precise results for the first time. Fields 
of use were tumor resection, orthognathic surgery, 
and trauma. The fields of ENT and CMF surgery 
overlap to some extent, and the largest user of AM—a 
CMF department that used about 150 PSIs/year—
reported operating on about 50 orbital fractures per 
year, using PSIs for all cases, that is, even for simple 
blow-out type fractures. While this contributed to 
their high volumes, the interpretation is complicated 
by the fact that some of these orbital floor implants 
were produced by milling and some by AM, and the 
company from which these were sourced did not 
divulge the specific ratio.
The plastic surgeons estimated using 10 to 20 plan-
ning models and saw guides and somewhat fewer 
PSIs per year, mainly in cleft palate reconstruction and 
tumor surgery. The ENT surgeons reported using 
cumulatively about 10 planning models and a similar 
number of PSIs per year.
One pediatric surgeon specialized in skull deform-
ity repair reported using both printed planning mod-
els and PSIs. In this case, about 10 models and 20 
implants were used per year. This usage was also 
mentioned by another responder (a physicist from the 
radiology department who operated the university’s 
own 3D printer).
Outside of the head region, one upper limb ortho-
pedic surgeon reported using 10 to 20 planning mod-
els per year, mainly for planning corrective operations 
of fracture malunions. This user found these models 
very helpful in planning complex operations and pre-
ferred them over virtual planning. Another orthope-
dic surgeon specializing in shoulder surgery estimated 
using about 5 to 10 commercial drill guides per year 
for positioning certain shoulder joint replacements. 
These drill guides include a model of the glenoid that 
they are modeled to fit and in theory make positioning 
of the implant foolproof. However, in practice, the 
user found that the results varied. While the surgeon 
ordered drill guides for only some cases, virtual plan-
ning was used on all patients.
All PSIs and saw guides were ordered from com-
mercial companies. In addition, almost all planning 
aids were ordered from commercial companies, with 
two exceptions: the pediatric surgeon identified as a 
heavy user produced preoperative models on a uni-
versity-owned printer that was operated by the radi-
ology department, and a maxillofacial department—the 
largest user of AM—reported owning a printer that 
they used for some preoperative models.
DISCUSSION
To our knowledge, this is the first nationwide survey 
concerning the clinical adoption of medical AM. We 
attempted to characterize the clinical use of medical 
AM in Finland occurring in 2016–2017, via email ques-
tionnaires and telephone interviews. Our results indi-
cate that AM had found routine use at university 
clinics with specialties relating to the head, that is, 
neurosurgery, ENT, plastic, and maxillofacial surgery. 
Outside of the head region, usage declined sharply; 
orthopedic surgery had some routine usage by a lim-
ited number of clinicians, and most of the other usage 
was experimental. The vast majority of prints (plan-
ning models, saw guides/drill guides, and PSIs) were 
ordered from commercial providers.
Many advanced forms of treatment are centralized 
to one or more of Finland’s five university hospitals. 
Because of this centralization, we assumed that the 
majority of non-dental AM applications would cur-
rently be found there. This was later confirmed by 
cross-referencing with providers of AM in Finland, 
who reported no major medical customers outside of 
tertiary-level hospitals.
The current study has several limitations. First, the 
nature of the study questions, limited and biased 
number of responders, and non-random sampling pre-
clude a meaningful quantitative analysis. Therefore, 
this study aims to characterize the adoption of AM 
technology in clinical care in a qualitative manner. 
Second, despite our efforts to follow the “web” of AM 
users, there may be individuals or groups that have 
been missed by this study because of our focus on 
tertiary-level hospitals and the bias of the authors’ 
connections. Third, since none of the reported num-
bers are based on reliable registries or statistics but 
rather estimates or recollections, there is a possibility 
of significant over- or underestimation.
BARRIERS TO ADOPTION
A common theme in the interviews with heavy users 
was that AM is irreplaceable for certain applications, 
even though no good studies exist to prove this. 
However, in the setting of rising cost pressures in 
health care, widescale adoption of new clinical tech-
nology requires evidence of efficacy. Many applica-
tions in the head area, such as cancer and complex 
trauma, are such that comparison trials between 
AM-assisted and traditional approaches are impossi-
ble because of strong clinician preference for AM. 
TABLE 3
Estimated yearly volumes of AM products used per specialty.
Preoperative models Saw/drill guides Implants
CMF 20 20 250
ENT 10 – 10
Plastic (Helsinki) 10–20 10–20 10
Neuro – – 50
Pediatric (Oulu) 10 – 20
Orthopedic 10–20 (Tampere) 5–10 (Oulu) –
AM: additive manufacturing.
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However, traditional means are still being used for 
many other applications such as prosthetic dentistry 
and orthopedics, and therefore comparative studies of 
efficacy would seem feasible.
A number of respondents reported that ordering 
AM products was difficult and slow, hence presenting 
a barrier to large-scale adoption. Since very few users 
produced and planned products in-house, design and 
ordering were usually done through online collabora-
tion with engineers from commercial 3D printing ven-
dors. For the heaviest users of AM, the imaging, 
design, production, and delivery of an implant and 
patient-specific guides could be done within 24 h if 
needed, based on an optimized and familiar workflow 
and co-location with the actual producer. However, 
depending on the provider, a 24-h timescale may not 
be possible for most applications.
A viable alternative for further integrating AM into 
clinical work and reducing turnaround time is to bring 
the design and production in-house (12). In several 
hospitals outside of Finland, the design is done either 
by hospital-employed design engineers or the clini-
cians themselves, and many institutions also have 
their own 3D printers, especially for applications other 
than implants. While somewhat time-consuming, 
many clinicians view this as a rewarding, more educa-
tive, and ultimately even faster process than using 
outside providers. In Finland, Oulu University has its 
own 3D printer for producing medical models but 
cannot serve other hospitals due to different regula-
tions applied to production for in-house versus out-
side customers.
Regulation of medical AM is also a complex issue 
internationally, and currently it remains the clinical 
end user’s responsibility to ascertain that the producer 
of their prints has the required certification. In Europe, 
even preoperative planning models are equated with 
medical devices and thus are required to meet several 
criteria, such as registration of the producer and a 
quality control system.
AM IN OFF-THE-SHELF PRODUCTION AND OTHER 
INVISIBLE USES
Numerically, the largest impact of AM on medical 
care has consisted of off-the-shelf implants—namely, 
components for orthopedic joint replacement—rather 
than patient-specific products. As this non-disruptive 
change in manufacturing technology has been invisi-
ble to clinicians, it was also not recognized by the cur-
rent study. While the exact percentage is unknown, 
several of the largest vendors are moving toward (or 
are already) producing parts of their joint replace-
ment products by AM. Components currently pro-
duced by AM include tibial components of knee 
prosthetics, cup components of hips, and augments 
for hip revision. Over 22,000 hip or knee joint replace-
ments were performed in Finland in 2015 (13), and 
similar numbers are estimated to have continued 
throughout the study period. Hence, the volumes of 
components are several orders of magnitude larger 
than those of PSIs.
Another noteworthy invisible usage is hearing 
aids, as the majority of device shells are produced by 
AM for purely economic reasons, while earpieces are 
individually printed based on scanned moldings of 
patients’ ears (8). Similarly, increased usage of AM 
for non-customized products is also seen in other 
industries (e.g. aerospace), with AM being used more 
frequently for mass production and less for prototyp-
ing and planning (14). Medical companies have 
adopted AM for the same reasons as other industries, 
namely, economics when producing limited runs of a 
product, and feasibility of geometries and structures 
(for instance, controlled surface porosity) not achiev-
able by traditional methodologies.
DENTAL USAGE OF AM
The dental sector in Finland is highly decentralized, 
making characterization by our chosen methodology 
impossible. However, most dental laboratories buy 
their supplies from two large distributors who also 
offer milling and AM services, both of which use the 
same subcontractor for metallic AM. We interviewed a 
representative of this company, and a dentist well 
known for his use of a 3D printer at his own practice.
Based on these data, we estimate that during the 
study period, metallic AM was mainly used in substruc-
tures for fixed prosthetic devices—a component difficult 
to produce by traditional methodologies. Approximately 
4 to 15 cobalt-chromium substructures were produced 
weekly by the domestic service provider, which amounts 
to around 500 per year. For other prosthetics in general, 
AM was still not a mainstream technology, with only 
about 20 bridges and 1 to 2 individual crowns produced 
per year. One reason for this is that these products are 
often produced from ceramics like zirconia, and print-
ing these types of materials is currently not as successful 
as that of metals (15). Moreover, many laboratories are 
already heavily invested in computer-aided design/
manufacture (CAD/CAM) milling technology for pros-
thetic and restorative devices, making them reluctant to 
switch to AM.
A commercial orthodontic product that uses a series 
of printed corrective dental films is available through 
certain private dentists, but most orthodontic work is 
done through traditional means. Usage of plastic drill 
guides and planning models is not mainstream, but 
some dentists do use them extensively. In dental pros-
thetic work, preoperative imaging is usually available, 
work may be spread out over many sessions with 
ample time for producing prints, and prints may be 
produced at a low cost using “prosumer”-level vat 
photopolymerization devices. Therefore, the biggest 
obstacle for widescale adoption seems to be lack of 
proven benefit, either in results, operative time, or 
cost.
PHySICAL PREOPERATIVE PLANNING AIDS 
VERSUS VIRTUAL PLANNING
The most well-known and earliest application of 
medical AM is the production of physical models for 
planning complex procedures. This usage was recog-
nized by our study, but the opinions about its useful-
ness varied. For example, some respondents found 
printed models useful, but many others felt that they 
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did not get any added value from them. Some 
respondents felt that the initial 3D printed models of 
complex pathologies had helped them understand 
the topology, but after having associated the models 
with certain imaging findings, they did not need 
prints of individual cases anymore.
Virtual planning using reconstructed computed 
tomography (CT) images is another option for preop-
erative planning (16, 17). It may be extended to the 
operating theater through intraoperative navigation, 
or even assistive robotics such as those currently com-
mercially available for joint replacement operations 
(18), which can be seen as the virtual planning-alter-
native to printed saw guides. Augmented reality (AR) 
applications are currently in development. Compared 
to physical models, virtual models have certain ben-
efits. For example, they do not require waiting for 
print completion, and they offer the ability to zoom, 
section, and manipulate at will, to try several destruc-
tive approaches like cutting the model without requir-
ing a new printed object, and computer-assisted 
planning such as structural integrity optimization 
using Finite-Element Modeling. A virtual model may 
also change over time, thus being more of a “4D 
model” and potentially better at approximating real-
world organs such as the heart, which constantly 
changes its geometry during the cardiac cycle. 
Drawbacks of virtual models, on the other hand, 
include inability to test tools or devices that have not 
been modeled, or the influence of the actual physical 
dexterity of the operator. There are studies suggesting 
a better grasp of proportions and relationships 
between structures, and especially a quicker ability to 
grasp these concepts, when using physical planning 
models compared to virtual 3D reconstructions or 
unprocessed CT slices (19). Current AR solutions are 
still quite cumbersome and do not approach the level 
of authenticity of a printed model. In our study, some 
respondents were enthusiastic about the possibilities 
of virtual planning, but others did not even like look-
ing at 3D renderings of CT images, preferring just tra-
ditional CT slices and envisioning the 3D anatomy by 
themselves.
CONCENTRATING ON AM VERSUS PATIENT-
SPECIFIC PRODUCTS IN GENERAL
Today, the lay public has a general concept of what 3D 
printing is, often associating it with material extru-
sion-type devices. However, they may not fully under-
stand machining or foundry technologies, or their 
capabilities. Indeed, our study revealed that many cli-
nicians thought certain patient-specific products 
(metallic orbital floor implants) were 3D printed when 
in fact they were often produced through machining.
From an engineering point of view, AM is just one 
of many production methodologies (although a very 
unique one) available for producing patient-specific 
products, which uses CAD/CAM. AM allows the 
creation of unique geometries that are not achieva-
ble through other means, and complex internal and 
surface structures are available “for free” (i.e. no 
extra machining cost). Using AM, implants may be 
constructed to include additional novel features, 
such as mechanisms for site-specific drug delivery 
and radio-frequency identification (20). However, 
when none of these properties are required, AM may 
not always be the most economical or otherwise pref-
erable methodology. The mechanical properties of 
AM-produced components may differ from those 
produced by traditional means, and a significant part 
of the AM literature is concerned with the influences 
of production methodology on factors such as osse-
ointegration, fatigue strength, and biocompatibility.
From a clinical perspective, clear evidence favor-
ing one methodology over another is lacking. 
However, the underlying manufacturing details as 
well as the associated engineering and biomedical 
issues remain of minor importance compared to cost, 
ease of planning, ordering, usage, and the changes 
caused to clinical practice/operative technique. 
Therefore, patient-specific products may be seen as 
the novel and disruptive technology regardless of the 
underlying production process. As such, future stud-
ies would benefit from including all individualized 
products based on clinical imaging through a CAD/
CAM workflow, instead of focusing only on 3D 
printed products.
In conclusion, we found that while medical AM 
has become routine for certain applications con-
cerning the head area, most specialties did not uti-
lize it in any way. Orthopedic surgery had the 
largest variation in terms of usage and perceived 
benefit between clinicians, and thoracic surgery and 
cardiology had some experimental use with unique 
challenges. Instead of technological issues such as 
lack of geometric fidelity, the largest obstacles for 
adopting AM into new applications were either the 
complexity of the ordering process or lack of per-
ceived benefit. Further research into the clinical 
adoption of these novel technologies should choose 
whether to concentrate on the production method-
ology of AM, including off-the-shelf components, or 
on CAD- or CAM-produced patient-specific prod-
ucts regardless of whether they use more traditional 
methodologies.
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